Christensen, C. et al. Diet, food, and nutritional exposures and inflammatory bowel disease or progression of disease: an umbrella review. Adv. Nutr. 15, 100219 (2024).
Chen, J. et al. Dietary antioxidant capacity, genetic susceptibility and polymorphism, and inflammatory bowel disease risk in a prospective cohort. Clin. Gastroenterol. Hepatol. https://doi.org/10.1016/j.cgh.2024.09.033 (2024).
Han, T. et al. The future landscape and framework of precision nutrition. Engineering 42, 15–25 (2024).
Petermann, I. et al. Mushroom intolerance: a novel diet-gene interaction in Crohn’s disease. Br. J. Nutr. 102, 506–508 (2009).
Ananthakrishnan, A. N. et al. Genetic polymorphisms in fatty acid metabolism modify the association between dietary n3: n6 intake and risk of ulcerative colitis: a prospective cohort study. Inflamm. Bowel Dis. 23, 1898–1904 (2017).
Levine, A. et al. Dietary guidance from the International Organization for the Study of Inflammatory Bowel Diseases. Clin. Gastroenterol. Hepatol. 18, 1381–1392 (2020).
Heaton, K. W., Thornton, J. R. & Emmett, P. M. Treatment of Crohn’s disease with an unrefined-carbohydrate, fibre-rich diet. Br. Med. J. 2, 764–766 (1979).
Hashash, J. G., Elkins, J., Lewis, J. D. & Binion, D. G. AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review. Gastroenterology 166, 521–532 (2024).
Svolos, V. et al. European Crohn’s and Colitis Organisation consensus on dietary management of inflammatory bowel disease. J. Crohns Colitis. 19, jjaf122 (2025).
Cuparencu, C. et al. Towards nutrition with precision: unlocking biomarkers as dietary assessment tools. Nat. Metab. 6, 1438–1453 (2024).
Sasson, A. N. et al. The role of precision nutrition in the modulation of microbial composition and function in people with inflammatory bowel disease. Lancet Gastroenterol. Hepatol. 6, 754–769 (2021).
Lee, B. Y. et al. Research gaps and opportunities in precision nutrition: an NIH workshop report. Am. J. Clin. Nutr. 116, 1877–1900 (2022).
Bush, C. L. et al. Toward the definition of personalized nutrition: a proposal by the American Nutrition Association. J. Am. Coll. Nutr. 39, 5–15 (2020).
Zeisel, S. H. Precision (personalized) nutrition: understanding metabolic heterogeneity. Annu. Rev. Food Sci. Technol. 11, 71–92 (2020).
Gibney, M. J. & Walsh, M. C. The future direction of personalised nutrition: my diet, my phenotype, my genes. Proc. Nutr. Soc. 72, 219–225 (2013).
Ferguson, L. R. et al. Guide and position of the International Society of Nutrigenetics/Nutrigenomics on personalised nutrition: Part 1 – Fields of precision nutrition. J. Nutrigenet Nutrigenomics 9, 12–27 (2016).
Ben-Yacov, O. et al. Personalized postprandial glucose response — targeting diet versus Mediterranean diet for glycemic control in prediabetes. Diabetes Care 44, 1980–1991 (2021).
Bermingham, K. M. et al. Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial. Nat. Med. 30, 1888–1897 (2024).
Berry, S. E. et al. Human postprandial responses to food and potential for precision nutrition. Nat. Med. 26, 964–973 (2020).
Zeevi, D. et al. Personalized nutrition by prediction of glycemic responses. Cell 163, 1079–1094 (2015).
Downs, S. M., Ahmed, S., Fanzo, J. & Herforth, A. Food environment typology: advancing an expanded definition, framework, and methodological approach for improved characterization of wild, cultivated, and built food environments toward sustainable diets. Foods 9, 532 (2020).
Chhibba, T. et al. Environmental risk factors of inflammatory bowel disease: toward a strategy of preventative health. J. Crohns Colitis 19, jjaf042 (2025).
Guo, A. et al. Early-life diet and risk of inflammatory bowel disease: a pooled study in two Scandinavian birth cohorts. Gut 73, 590–600 (2024).
Khalili, H. et al. Diet quality and risk of older-onset Crohn’s disease and ulcerative colitis. J. Crohns Colitis 17, 746–753 (2023).
Khalili, H. et al. Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn’s disease: results from two large prospective cohort studies. Gut 69, 1637–1644 (2020).
Chen, J. et al. Composition of plant-based diets and the incidence and prognosis of inflammatory bowel disease: a multinational retrospective cohort study. Lancet Reg. Health Eur. 52, 101264 (2025).
Chen, J. et al. Intake of ultra-processed foods is associated with an increased risk of Crohn’s disease: a cross-sectional and prospective analysis of 187 154 participants in the UK Biobank. J. Crohns Colitis 17, 535–552 (2023).
Lopes, E. W. et al. Lifestyle factors for the prevention of inflammatory bowel disease. Gut https://doi.org/10.1136/gutjnl-2022-328174 (2022).
Powe, C. E. et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N. Engl. J. Med. 369, 1991–2000 (2013).
Wang, Y. et al. Serum 25-hydroxyvitamin D, type 2 diabetes, and liver-related outcomes: secondary data analysis of a prospective recruited cohort. Hepatol. Commun. 7, e0291 (2023).
Ananthakrishnan, A. N. et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease. Inflamm. Bowel Dis. 19, 1921–1927 (2013).
Dan, L. et al. Circulating 25-hydroxyvitamin D concentration can predict bowel resection risk among individuals with inflammatory bowel disease in a longitudinal cohort with 13 years of follow-up. Int. J. Surg. 110, 4275–4285 (2024).
Armstrong, H. K. et al. Unfermented β-fructan fibers fuel inflammation in select inflammatory bowel disease patients. Gastroenterology 164, 228–240 (2023).
Gold, S., Park, S., Katz, J., McClave, S. & Martindale, R. The evolving guidelines on fiber intake for patients with inflammatory bowel disease; from exclusion to texture modification. Curr. Gastroenterol. Rep. 27, 23 (2025).
Lewis, J. D. et al. A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn’s disease. Gastroenterology 161, 837–852.e9 (2021).
Godny, L. et al. Mechanistic implications of the Mediterranean diet in patients with newly diagnosed Crohn’s disease: multiomic results from a prospective cohort. Gastroenterology 168, 952–964.e2 (2025).
Chicco, F. et al. Multidimensional impact of Mediterranean diet on IBD patients. Inflamm. Bowel Dis. 27, 1–9 (2021).
Chen, H. et al. Meat consumption and all-cause mortality in 5763 patients with inflammatory bowel disease: A retrospective cohort study. EClinicalMedicine 47, 101406 (2022).
Tan, H. E. et al. The gut-brain axis mediates sugar preference. Nature 580, 511–516 (2020).
Lyu, Q. et al. A brain-to-gut signal controls intestinal fat absorption. Nature 634, 936–943 (2024).
Fung, C. et al. Nutrients activate distinct patterns of small-intestinal enteric neurons. Nature https://doi.org/10.1038/s41586-025-09228-z (2025).
Piovani, D. et al. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology 157, 647–659.e4 (2019).
Chen, J. et al. Ambient air pollution and risk of enterotomy, gastrointestinal cancer, and all-cause mortality among 4,708 individuals with inflammatory bowel disease: a prospective cohort study. Env. Health Perspect. 131, 77010 (2023).
Estevinho, M. M. et al. Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms. Gut 74, 477–486 (2025).
Cheng, S. L. et al. Multiomic signatures of traffic-related air pollution in london reveal potential short-term perturbations in gut microbiome-related pathways. Env. Sci. Technol. 58, 8771–8782 (2024).
Bouranis, J. A. et al. Interplay between cruciferous vegetables and the gut microbiome: a multi-omic approach. Nutrients 15, 42 (2022).
Hu, X. L. et al. Aryl hydrocarbon receptor utilises cellular zinc signals to maintain the gut epithelial barrier. Nat. Commun. 14, 5431 (2023).
Steemburgo, T., Martinez, J. A., Marchetti, J., Rosado, E. L. & dos Santos, K. in Precision Nutrition (eds Heber, D., Li, Z. & Ordovas, J.) 23–42 (Academic, 2024).
Amir Shaghaghi, M. et al. The SLC2A14 gene, encoding the novel glucose/dehydroascorbate transporter GLUT14, is associated with inflammatory bowel disease. Am. J. Clin. Nutr. 106, 1508–1513 (2017).
Costea, I. et al. Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric Crohn’s disease. Gastroenterology 146, 929–931 (2014).
Sun, S. et al. Dietary anthocyanin intake, genetic risk, and incident ulcerative colitis: a prospective cohort study. Phytother. Res. 38, 5782–5792 (2024).
Herrera-Luis, E., Benke, K., Volk, H., Ladd-Acosta, C. & Wojcik, G. L. Gene-environment interactions in human health. Nat. Rev. Genet. 25, 768–784 (2024).
Yilmaz, F. et al. Reconstruction of the human amylase locus reveals ancient duplications seeding modern-day variation. Science 386, eadn0609 (2024).
Robinson, M. R. et al. Genotype-covariate interaction effects and the heritability of adult body mass index. Nat. Genet. 49, 1174–1181 (2017).
Karow, J. Genomics England’s Generation Study Starts Enrolling First Newborns https://www.genomeweb.com/sequencing/genomics-englands-generation-study-starts-enrolling-first-newborns (genomeweb, 2024).
Ideraabdullah, F. Y. & Zeisel, S. H. Dietary modulation of the epigenome. Physiol. Rev. 98, 667–695 (2018).
Godfrey, K. M. et al. Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes 60, 1528–1534 (2011).
Chen, J. et al. Exposure to air pollution increases susceptibility to ulcerative colitis through epigenetic alterations in CXCR2 and MHC class III region. EBioMedicine 110, 105443 (2024).
Zhang, H. et al. Altered DNA methylation within DNMT3A, AHRR, LTA/TNF loci mediates the effect of smoking on inflammatory bowel disease. Nat. Commun. 15, 595 (2024).
Joustra, V. et al. Systematic review and meta-analysis of peripheral blood DNA methylation studies in inflammatory bowel disease. J. Crohns Colitis 17, 185–198 (2023).
Schirmer, M., Garner, A., Vlamakis, H. & Xavier, R. J. Microbial genes and pathways in inflammatory bowel disease. Nat. Rev. Microbiol. 17, 497–511 (2019).
Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).
Bolte, L. A. et al. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome. Gut 70, 1287–1298 (2021).
Nguyen, L. H. et al. Association between sulfur-metabolizing bacterial communities in stool and risk of distal colorectal cancer in men. Gastroenterology 158, 1313–1325 (2020).
Chen, J., Dan, L., Sun, Y., Fu, T. & Wang, X. The sulfur microbial diet and prognosis of individuals with inflammatory bowel disease in a prospective cohort study [abstract P1150]. J. Crohns Colitis 18, i2045 (2024).
Day, A. S. et al. Functional profiling demonstrates that a sulfide-reducing diet achieves microenvironmental targets in ulcerative colitis. Inflamm. Bowel Dis. 31, 3160–3171 (2025).
Zhang, C. et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 4, 232–241 (2010).
Clooney, A. G. et al. Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study. Gut 70, 499–510 (2021).
Gacesa, R. et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732–739 (2022).
Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016).
Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).
Li, F. et al. Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation. Cell 188, 1226–1247.e18 (2025).
Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
Christensen, L., Roager, H. M., Astrup, A. & Hjorth, M. F. Microbial enterotypes in personalized nutrition and obesity management. Am. J. Clin. Nutr. 108, 645–651 (2018).
Cheng, Y. et al. CarveAdornCurate: a versatile cloud-based platform for constructing multiscale metabolic models. Trends Biotechnol. 43, 1234–1259 (2025).
Preto, A. J. et al. Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease. J. Crohns Colitis 19, jjae197 (2025).
Panaccione, R. et al. Efficacy and safety of adalimumab by disease duration: analysis of pooled data from Crohn’s disease studies. J. Crohns Colitis 13, 725–734 (2019).
Ben-Yacov, O. et al. Gut microbiome modulates the effects of a personalised postprandial-targeting (PPT) diet on cardiometabolic markers: a diet intervention in pre-diabetes. Gut 72, 1486–1496 (2023).
Mathers, J. C. Dietary fibre and health: the story so far. Proc. Nutr. Soc. 82, 120–129 (2023).
Albenberg, L. et al. A diet low in red and processed meat does not reduce rate of Crohn’s disease flares. Gastroenterology 157, 128–136.e5 (2019).
Attauabi, M. et al. Influence of genetics, immunity and the microbiome on the prognosis of inflammatory bowel disease (IBD Prognosis Study): the protocol for a Copenhagen IBD inception cohort study. BMJ Open. 12, e055779 (2022).
Pittet, V. et al. Cohort profile update: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int. J. Epidemiol. 48, 385–386f (2019).
Braun, T. et al. Diet-omics in the Study of Urban and Rural Crohn Disease Evolution (SOURCE) cohort. Nat. Commun. 15, 3764 (2024).
Chen, J., Li, X. & Wang, X. NE-IBD Study Group Characteristics of a prospective cohort in Chinese population with inflammatory bowel disease: results from the Omics, Nutrition, and Environment Synthesis for Inflammatory Bowel Disease (ONE-IBD) study [abstract DOP091]. J. Crohns Colitis 20, i323 (2026).
Olén, O. et al. Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964-2014. Gut 69, 453–461 (2020).
Rezaie, A., Quan, H., Fedorak, R. N., Panaccione, R. & Hilsden, R. J. Development and validation of an administrative case definition for inflammatory bowel diseases. Can. J. Gastroenterol. 26, 711–717 (2012).
Deng, M. et al. Higher dietary fibre intake is associated with lower risk of inflammatory bowel disease: prospective cohort study. Aliment. Pharmacol. Ther. 58, 516–525 (2023).
Bhagwat, S., Haytowitz, D. B., Wasswa-Kintu, S. I. & Holden, J. M. USDA develops a database for flavonoids to assess dietary intakes. Procedia Food Sci. 2, 81–86 (2013).
Menichetti, G., Barabási, A. L. & Loscalzo, J. Chemical complexity of food and implications for therapeutics. N. Engl. J. Med. 392, 1836–1845 (2025).
Lu, S. Y., Dan, L., Sun, S., Fu, T. & Chen, J. Dietary quercetin intake is associated with lower ulcerative colitis risk but not Crohn’s disease in a prospective cohort study and in vivo experiments. Food Funct. 15, 6553–6564 (2024).
Maruvada, P. et al. Perspective: dietary biomarkers of intake and exposure — exploration with omics approaches. Adv. Nutr. 11, 200–215 (2020).
Willett, W. Nutritional Epidemiology 3rd edn (Oxford Univ. Press, 2012).
Gachabayov, M., Dyatlov, A. & Bergamaschi, R. Hawthorne effect should be controlled for in quality control studies. JAMA Surg. 154, 977 (2019).
Nybacka, S. et al. Within- and between-subject variation in dietary intake of fermentable oligo-, di-, monosaccharides, and polyols among patients with irritable bowel syndrome. Curr. Dev. Nutr. 3, nzy101 (2019).
Dalakleidi, K. V., Papadelli, M., Kapolos, I. & Papadimitriou, K. Applying image-based food-recognition systems on dietary assessment: a systematic review. Adv. Nutr. 13, 2590–2619 (2022).
Mertes, G. et al. Measuring and localizing individual bites using a sensor augmented plate during unrestricted eating for the aging population. IEEE J. Biomed. Health Inform. 24, 1509–1518 (2020).
Sempionatto, J. R., Montiel, V. R., Vargas, E., Teymourian, H. & Wang, J. Wearable and mobile sensors for personalized nutrition. ACS Sens. 6, 1745–1760 (2021).
Eom, K. S. et al. Sensitive and non-invasive cholesterol determination in saliva via optimization of enzyme loading and platinum nano-cluster composition. Analyst 145, 908–916 (2020).
Wang, M. et al. A wearable electrochemical biosensor for the monitoring of metabolites and nutrients. Nat. Biomed. Eng. 6, 1225–1235 (2022).
Shi, Z. et al. Wireless and battery-free wearable biosensing of riboflavin in sweat for precision nutrition. Biosens. Bioelectron. 251, 116136 (2024).
Min, J. et al. Continuous biochemical profiling of the gastrointestinal tract using an integrated smart capsule. Nat. Electron. https://doi.org/10.1038/s41928-025-01407-0 (2025).
Jacob, M. et al. A targeted metabolomics approach for clinical diagnosis of inborn errors of metabolism. Anal. Chim. Acta 1025, 141–153 (2018).
Ning, L. et al. Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts. Nat. Commun. 14, 7135 (2023).
Harun-Or-Rashid, M., Mirzaei, S. & Nasiri, N. Nanomaterial innovations and machine learning in gas sensing technologies for real-time health diagnostics. ACS Sens. 10, 1620–1640 (2025).
Fritsch, J. et al. Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clin. Gastroenterol. Hepatol. 19, 1189–1199.e30 (2021).
Geng, J. et al. Dietary glucosamine supplement use and lower surgery risk in individuals with inflammatory bowel disease: a prospective cohort study. Eur. J. Nutr. 64, 191 (2025).
Hirten, R. P. et al. Physiological data collected from wearable devices identify and predict inflammatory bowel disease flares. Gastroenterology https://doi.org/10.1053/j.gastro.2024.12.024 (2025).
Kirk, D., Catal, C. & Tekinerdogan, B. Precision nutrition: a systematic literature review. Computers Biol. Med. 133, 104365 (2021).
Lacruz-Pleguezuelos, B. et al. AI4Food, a feasibility study for the implementation of automated devices in the nutritional advice and follow up within a weight loss intervention. Clin. Nutr. 48, 80–89 (2025).
Wu, H. et al. The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study. Cell Metab. 32, 379–390.e3 (2020).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04283864 (2026).
Greathouse, K. L. & Choudhury, A. Precision nutrition and the gut microbiome: Harnessing AI to revolutionize cancer prevention and therapy. Cell Host Microbe 33, 766–776 (2025).
Adams, S. H. et al. Perspective: guiding principles for the implementation of personalized nutrition approaches that benefit health and function. Adv. Nutr. 11, 25–34 (2020).
Turner, D. et al. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160, 1570–1583 (2021).
Le Berre, C. & Peyrin-Biroulet, L. Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD. Gastroenterology 160, 1452–1460.e21 (2021).
Yanai, H. et al. The Crohn’s disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn’s disease (CDED-AD): an open-label, pilot, randomised trial. Lancet Gastroenterol. Hepatol. 7, 49–59 (2022).
Shahinfar, H. et al. Administration of dietary antioxidants for patients with inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled clinical trials. Complement. Ther. Med. 63, 102787 (2021).
Ajabnoor, S. M., Thorpe, G., Abdelhamid, A. & Hooper, L. Long-term effects of increasing omega-3, omega-6 and total polyunsaturated fats on inflammatory bowel disease and markers of inflammation: a systematic review and meta-analysis of randomized controlled trials. Eur. J. Nutr. 60, 2293–2316 (2021).
Rudbaek, J. J. et al. Deciphering the different phases of preclinical inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 21, 86–100 (2024).
Singh, S., Boland, B. S., Jess, T. & Moore, A. A. Management of inflammatory bowel diseases in older adults. Lancet Gastroenterol. Hepatol. 8, 368–382 (2023).
Sinha, S. et al. Connecting precision nutrition with the food is medicine approach. Trends Endocrinol. Metab. 36, 511–520 (2025).
Wang, Z. et al. Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn’s disease. Cell Metab. https://doi.org/10.1016/j.cmet.2025.01.007 (2025).
Aldubayan, M. A. et al. Empowering consumers to PREVENT diet-related diseases through OMICS sciences (PREVENTOMICS): protocol for a parallel double-blinded randomised intervention trial to investigate biomarker-based nutrition plans for weight loss. BMJ Open. 12, e051285 (2022).
Honap, S., Zou, G., Danese, S., Peyrin-Biroulet, L. & Jairath, V. Personalized (N-of-1) clinical trials for inflammatory bowel disease: opportunities and challenges. Clin. Gastroenterol. Hepatol. 23, 14–23 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05054153 (2023).
Zhang, K. et al. Quantification of personalized glycemic sensitivity to food and its potential for precision nutrition in a series of n-of-1 trials. Am. J. Clin. Nutr. https://doi.org/10.1016/j.ajcnut.2025.04.015 (2025).
Kaplan, H. C. et al. Personalized research on diet in ulcerative colitis and Crohn’s disease: a series of N-of-1 diet trials. Am. J. Gastroenterol. 117, 902–917 (2022).
Sudhakar, P. et al. Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches? Gut 72, 192–204 (2023).
Cummins, S. & Macintyre, S. “Food deserts” — evidence and assumption in health policy making. BMJ 325, 436–438 (2002).
Xu, R. et al. Integrating human activity into food environments can better predict cardiometabolic diseases in the United States. Nat. Commun. 14, 7326 (2023).
Zhao, M. et al. Systematic review with meta-analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations. Aliment. Pharmacol. Ther. 55, 266–276 (2022).
Guasch-Ferré, M. et al. Precision nutrition for cardiometabolic diseases. Nat. Med. 31, 1444–1453 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06657001 (2025).
Xie, Z. et al. Randomized controlled trial for time-restricted eating in healthy volunteers without obesity. Nat. Commun. 13, 1003 (2022).
Damas, O. M. et al. A pilot randomized control trial to assess the adjunctive effect of diet on response to advanced therapies in patients with Ulcerative colitis. Clin. Gastroenterol. Hepatol. https://doi.org/10.1016/j.cgh.2025.03.020 (2025).
Armet, A. et al. Preliminary results from a pilot trial comparing effects of a plant-based fasting mimicking diet with a caloric-sufficient diet on depressive symptoms in patients with inflammatory bowel disease [abstract 1003]. Gastroenterology 169, S-236 (2025).
Macdonald, H. M. et al. 25-Hydroxyvitamin D threshold for the effects of vitamin D supplements on bone density: secondary analysis of a randomized controlled trial. J. Bone Min. Res. 33, 1464–1469 (2018).
Li, J., Martin, C. & Fernie, A. Biofortification’s contribution to mitigating micronutrient deficiencies. Nat. Food 5, 19–27 (2024).
Wallnoefer, L. M., Riefler, P. & Meixner, O. What drives the choice of local seasonal food? Analysis of the importance of different key motives. Foods 10, 2715 (2021).
Whelan, K., Bancil, A. S., Lindsay, J. O. & Chassaing, B. Ultra-processed foods and food additives in gut health and disease. Nat. Rev. Gastroenterol. Hepatol. 21, 406–427 (2024).
Wellens, J. et al. Cooking methods affect advanced glycation end products and lipid profiles: a randomized cross-over study in healthy subjects. Cell Rep. Med. 6, 102091 (2025).
Aharoni Frutkoff, Y. et al. Tasty & healthy flexible diet induces clinical and biological remission in children and young adults with mild-moderate Crohn’s Disease similar to EEN: results from the “TASTI-MM” randomized, physician-blinded, controlled trial [abstract OP02]. J. Crohns Colitis 19, i4 (2025).
Anand, S. S. et al. Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: a report from the workshop convened by the World Heart Federation. J. Am. Coll. Cardiol. 66, 1590–1614 (2015).
Meyer, A. et al. Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn’s disease and ulcerative colitis. Aliment. Pharmacol. Ther. 59, 558–568 (2024).
Herforth, A. et al. Cost and Affordability of Healthy Diets Across and Within Countries (FAO, 2020).
Willett, W. et al. Food in the Anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems. Lancet 393, 447–492 (2019).
Yang, Q. et al. A high cholesterol diet aggravates experimental colitis through SREBP2-modulated endocytosis and degradation of occludin and Zo-1 proteins. FEBS J. https://doi.org/10.1111/febs.17269 (2024).
Khalili, H. et al. Dietary iron and heme iron consumption, genetic susceptibility, and risk of Crohn’s disease and ulcerative colitis. Inflamm. Bowel Dis. 23, 1088–1095 (2017).
Ferreira, P. et al. Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgamma apoptotic genes in modulating Crohn’s disease activity. Clin. Nutr. 29, 819–823 (2010).
Laing, B., Han, D. Y. & Ferguson, L. R. Candidate genes involved in beneficial or adverse responses to commonly eaten brassica vegetables in a New Zealand Crohn’s disease cohort. Nutrients 5, 5046–5064 (2013).
Nardone, O. M. et al. Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease. Nutrients 13, 1290 (2021).
Jiang, F. et al. The contribution of dietary advanced glycation end-products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study. Aliment. Pharmacol. Ther. 60, 1075–1086 (2024).
Sun, Y. et al. The contribution of genetic risk and lifestyle factors in the development of adult-onset inflammatory bowel disease: a prospective cohort study. Am. J. Gastroenterol. 118, 511–522 (2023).
Stensballe, A. et al. Impaired Abcb1a function and red meat in a translational colitis mouse model induces inflammation and alters microbiota composition. Front. Med. 10, 1200317 (2023).
Haskey, N. et al. A Mediterranean-like fat blend protects against the development of severe colitis in the mucin-2 deficient murine model. Gut Microbes 14, 2055441 (2022).
Denizot, J. et al. Diet-induced hypoxia responsive element demethylation increases CEACAM6 expression, favouring Crohn’s disease-associated Escherichia coli colonisation. Gut 64, 428–437 (2015).
Schwarzfischer, M. et al. TiO2 nanoparticles abrogate the protective effect of the Crohn’s disease-associated variation within the PTPN22 gene locus. Gut 72, 1101–1114 (2023).
Nichols, B. et al. Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn’s disease. Am. J. Clin. Nutr. 119, 885–895 (2024).
Verburgt, C. M. et al. Successful dietary therapy in paediatric Crohn’s disease is associated with shifts in bacterial dysbiosis and inflammatory metabotype towards healthy controls. J. Crohns Colitis 17, 61–72 (2023).
Verburgt, C. M., Sigall Boneh, R. & Dunn, K. Intestinal permeability improvement with nutritional therapy is associated with specific microbiome profiles and functional pathways in pediatric Crohn’s disease. Gastroenterology 164, 1025–1026 (2023).
Turpin, W. et al. Mediterranean-like dietary pattern associations with gut microbiome composition and subclinical gastrointestinal inflammation. Gastroenterology 163, 685–698 (2022).
Häcker, D. et al. Exclusive enteral nutrition initiates individual protective microbiome changes to induce remission in pediatric Crohn’s disease. Cell Host Microbe 32, 2019–2034.e8 (2024).
Lv, Y. et al. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn’s disease. Clin. Nutr. 42, 116–128 (2023).
Cox, S. R. et al. Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology 158, 176–188.e7 (2020).
Godny, L. et al. Fruit consumption is associated with alterations in microbial composition and lower rates of pouchitis. J. Crohns Colitis 13, 1265–1272 (2019).
Suskind, D. L. et al. Clinical and fecal microbial changes with diet therapy in active inflammatory bowel disease. J. Clin. Gastroenterol. 52, 155–163 (2018).
Lewis, J. D. et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s disease. Cell Host Microbe 18, 489–500 (2015).
Fu, T. et al. Sugar-sweetened beverages, artificially sweetened beverages and natural juices and risk of inflammatory bowel disease: a cohort study of 121,490 participants. Aliment. Pharmacol. Ther. 56, 1018–1029 (2022).
Jantchou, P., Morois, S., Clavel-Chapelon, F., Boutron-Ruault, M. C. & Carbonnel, F. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am. J. Gastroenterol. 105, 2195–2201 (2010).
Ananthakrishnan, A. N. et al. Systematic review and meta-analysis: phenotype and clinical outcomes of older-onset inflammatory bowel disease. J. Crohns Colitis 10, 1224–1236 (2016).